Pacs [PACS] vs Acadia Healthcare [ACHC] Detailed Stock Comparison
Pacs
NYSE
Loading...
Acadia Healthcare
NASDAQ
Loading...
TLDR: Quick Comparison Summary
Based on 19 vital metrics comparison: Pacs wins in 6 metrics, Acadia Healthcare wins in 12 metrics, with 0 ties. Acadia Healthcare appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Pacs | Acadia Healthcare | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 19.41 | 13.80 | Acadia Healthcare |
| Price-to-Book Ratio | 3.15 | 0.62 | Acadia Healthcare |
| Debt-to-Equity Ratio | 469.36 | 74.74 | Acadia Healthcare |
| PEG Ratio | 6.61 | -0.22 | Acadia Healthcare |
| EV/EBITDA | 17.61 | 6.76 | Acadia Healthcare |
| Profit Margin (TTM) | 2.59% | 4.31% | Acadia Healthcare |
| Operating Margin (TTM) | 0.07% | 16.37% | Acadia Healthcare |
| EBITDA Margin (TTM) | 0.07% | 16.37% | Acadia Healthcare |
| Return on Equity | 110.96% | 4.83% | Pacs |
| Return on Assets (TTM) | 3.21% | 4.92% | Acadia Healthcare |
| Free Cash Flow (TTM) | $-109.11M | $-560.69M | Pacs |
| 1-Year Return | -71.61% | -73.19% | Pacs |
| Price-to-Sales Ratio (TTM) | 0.52 | 0.60 | Pacs |
| Enterprise Value | $4.39B | $4.36B | Pacs |
| EV/Revenue Ratio | 1.23 | 1.35 | Pacs |
| Gross Profit Margin (TTM) | 15.67% | 96.72% | Acadia Healthcare |
| Revenue per Share (TTM) | $27 | $35 | Acadia Healthcare |
| Earnings per Share (Diluted) | $0.61 | $1.52 | Acadia Healthcare |
| Beta (Stock Volatility) | N/A | 0.88 | N/A |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Pacs vs Acadia Healthcare Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Pacs | -1.59% | 1.73% | 0.95% | 18.72% | -8.29% | -9.28% |
| Acadia Healthcare | 0.56% | 3.68% | -1.02% | -8.89% | -45.98% | -47.46% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Pacs | -71.61% | -51.13% | -51.13% | -51.13% | -51.13% | -51.13% |
| Acadia Healthcare | -73.19% | -74.08% | -31.41% | -71.29% | 353.81% | 114.20% |
Performance & Financial Health Analysis: Pacs vs Acadia Healthcare
| Metric | PACS | ACHC |
|---|---|---|
| Market Information | ||
| Market Cap | $1.84B | $1.94B |
| Market Cap Category | Small cap | Small cap |
| 10 Day Avg. Volume | 403,171 | 3,251,860 |
| 90 Day Avg. Volume | 479,024 | 2,130,137 |
| Last Close | $11.73 | $21.42 |
| 52 Week Range | $8.28 - $43.92 | $17.13 - $82.41 |
| % from 52W High | -73.29% | -74.01% |
| All-Time High | $43.92 (Oct 28, 2024) | $89.85 (Nov 28, 2022) |
| % from All-Time High | -73.29% | -76.16% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.29% | 0.09% |
| Quarterly Earnings Growth | N/A | -0.62% |
| Financial Health | ||
| Profit Margin (TTM) | 0.03% | 0.04% |
| Operating Margin (TTM) | 0.00% | 0.16% |
| Return on Equity (TTM) | 1.11% | 0.05% |
| Debt to Equity (MRQ) | 469.36 | 74.74 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $3.75 | $34.05 |
| Cash per Share (MRQ) | $0.48 | $1.42 |
| Operating Cash Flow (TTM) | $99.09M | $424.81M |
| Levered Free Cash Flow (TTM) | $1.62B | $-267,134,000 |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | N/A |
| Last 12-Month Dividend | N/A | N/A |
Valuation & Enterprise Metrics Analysis: Pacs vs Acadia Healthcare
| Metric | PACS | ACHC |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 19.41 | 13.80 |
| Forward P/E | 6.61 | 5.72 |
| PEG Ratio | 6.61 | -0.22 |
| Price to Sales (TTM) | 0.52 | 0.60 |
| Price to Book (MRQ) | 3.15 | 0.62 |
| Market Capitalization | ||
| Market Capitalization | $1.84B | $1.94B |
| Enterprise Value | $4.39B | $4.36B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 1.23 | 1.35 |
| Enterprise to EBITDA | 17.61 | 6.76 |
| Risk & Other Metrics | ||
| Beta | N/A | 0.88 |
| Book Value per Share (MRQ) | $3.75 | $34.05 |
Financial Statements Comparison: Pacs vs Acadia Healthcare
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | PACS | ACHC |
|---|---|---|
| Revenue/Sales | $981.85M | $770.51M |
| Cost of Goods Sold | $827.98M | $28.34M |
| Gross Profit | $153.87M | $742.16M |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | $710,000 | $78.50M |
| EBITDA | $5.58M | $125.53M |
| Pre-Tax Income | $-12.38M | $13.47M |
| Income Tax | $-1.47M | $4.40M |
| Net Income (Profit) | $-10.91M | $9.06M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | PACS | ACHC |
|---|---|---|
| Cash & Equivalents | $73.37M | $91.24M |
| Total Current Assets | $800.65M | $638.95M |
| Total Current Liabilities | $468.10M | $473.35M |
| Long-Term Debt | $2.54B | $2.29B |
| Total Shareholders Equity | $578.23M | $3.17B |
| Retained Earnings | $100.50M | $348.45M |
| Property, Plant & Equipment | $2.15B | $597.87M |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | PACS | ACHC |
|---|---|---|
| Operating Cash Flow | $-33.46M | $30.01M |
| Capital Expenditures | $-111.48M | $43,000 |
| Free Cash Flow | $-76.67M | $-163.15M |
| Debt Repayment | $-465.05M | $-1.71B |
| Common Stock Repurchase | N/A | $-46.88M |
Short Interest & Institutional Ownership Analysis
| Metric | PACS | ACHC |
|---|---|---|
| Shares Short | 2.47M | 10.54M |
| Short Ratio | 4.79 | 6.05 |
| Short % of Float | N/A | 0.14% |
| Average Daily Volume (10 Day) | 403,171 | 3,251,860 |
| Average Daily Volume (90 Day) | 479,024 | 2,130,137 |
| Shares Outstanding | 147.77M | 91.78M |
| Float Shares | 43.04M | 90.63M |
| % Held by Insiders | 0.72% | 0.02% |
| % Held by Institutions | 0.29% | 1.16% |
Dividend Analysis & Yield Comparison: Pacs vs Acadia Healthcare
| Metric | PACS | ACHC |
|---|---|---|
| Last 12-Month Dividend | N/A | N/A |
| Last 12-Month Dividend Yield | N/A | N/A |
| 3-Year Avg Annual Dividend | N/A | N/A |
| 3-Year Avg Dividend Yield | N/A | N/A |
| 3-Year Total Dividends | N/A | N/A |
| Ex-Dividend Date | N/A | N/A |